Real-world experience with riociguat as potential bridging therapy in patients with chronic thromboembolic pulmonary hypertension: a case series.

Autor: Balasubramanian VP; Division of Pulmonary Disease and Critical Care Medicine, University of California, Fresno, CA, USA., Beutner M; Division of Pulmonary Disease and Critical Care Medicine, University of California, Fresno, CA, USA., Gill K; Division of Pulmonary Disease and Critical Care Medicine, University of California, Fresno, CA, USA., Kakol M; Division of Pulmonary Disease and Critical Care Medicine, University of California, Fresno, CA, USA.; University of New Mexico medical center at Albuquerque, NM, USA., Melendres-Groves L; Division of Pulmonary Disease and Critical Care Medicine, University of California, Fresno, CA, USA.; University of New Mexico medical center at Albuquerque, NM, USA.
Jazyk: angličtina
Zdroj: Pulmonary circulation [Pulm Circ] 2020 Apr 16; Vol. 10 (2), pp. 2045894019898377. Date of Electronic Publication: 2020 Apr 16 (Print Publication: 2020).
DOI: 10.1177/2045894019898377
Databáze: MEDLINE